The New Zealand Government has changed the law surrounding the distribution of the Pfizer/BioNTech vaccine following a High Court ruling that determined widespread access to the vaccine was unlawful and in violation of the Medicines Act. In a court case between Nga Kaitiaki Tuku Ihu Medical Action Society (KTI) and the Minister of Health, KTI argued that the Pfizer vaccine has not completed its clinical trial phase and should not be made available to the wider population in accordance with section 23 of the act. On May 18, the High Court ruled in favour of KTI, stating that it was “reasonably arguable” that the provisional approval for the vaccine in the entire adult population was “problematic.” Minister for Health Andrew Little subsequently announced the act would be receiving an immediate amendment, and the Medicines Amendment Bill was introduced and passed on May 19, the following day. Section 23(1) of the …